COMPANY PROFILE · /pathos-ai
P
Pathos AI
Pathos AI develops machine learning platforms for translational and computational biology, enabling drug discovery and development at scale. The company raised $467M across three rounds, achieving the highest average per-round capital of any active private AI drug discovery company.
Fresh · 5d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$467M
OVERVIEW
Highest average capital per round ($156M average) among active private companies in AI drug discovery. Focused on building molecular and cellular understanding for target identification and compound design.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.